MTX-325

N/A

Report date: 2025/06/05 16:57:26
NME

Base Information

Drug NameMTX-325
Drug Alias NameMTX-325MTX325MTX-115325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 30 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 30
Therapy Area/IndicationsPelizaeus-Merzbacher DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie IncMission Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMission Therapeutics
Inactive CompaniesN/A
Active IndicationsPelizaeus-Merzbacher DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A